AB0221 Does Etanercept Maintain Its Efficacy in the Elderly Population. A Single Center Retrospective Analysis

Background Biological drugs have dramatically improved the prognosis of rheumatoid arthritis (RA), especially in those with early disease. These patientsare often in younger age with fewer co-morbidities. Recent Canadian data suggests the highest incidence and prevalence of RA is in the 55-85 year old age group, often with associated co-morbidities, poly-pharmacy, and often longstanding disease. Objectives The objective of this real world …